logo
Share SHARE
FONT-SIZE Plus   Neg

Protalix Says FDA Extends Taliglucerase Alfa PDUFA Date To May 1, 2012

Protalix BioTherapeutics, Inc. (PLX) Tuesday said it has received notification from the U.S. Food and Drug Administration that the FDA has extended the Prescription Drug User Fee Act goal date of the New Drug Application for taliglucerase alfa to May 1, 2012, a three-month extension from the previous PDUFA date of February 1, 2012.

Taliglucerase alfa is the Company's proprietary plant cell expressed recombinant form of human Glucocerebrosidase, which is being developed for the treatment of Gaucher disease.

In November 2011, the Company submitted certain clinical information regarding taliglucerase alfa in response to an FDA request. This request related mainly to the presentation of select data provided in the NDA.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Apple typically schedules its iPhone launch event in September every year. However, the tech giant has not made any official announcement about the new iPhone 7 event date yet. According to popular and reliable leaker Evan Blass, Apple will ship iPhone 7 during "the week of September 12." He later... At Home Group Inc., the home décor retail store with 115 stores in 29 states is planning to go public. The pricing of initial public offering is expected in a range of $14 to $16 per share. The company in a filing with the SEC said it has got the approval to list the shares on the NYSE under symbol "HOME." McDonald's Corp. has suspended sales of Big Macs in Venezuela as the fast food chain is unable to source buns - one of the key components of a burger. Venezuela is suffering from food shortages recently due to an ongoing economic and political crisis.
comments powered by Disqus
Follow RTT